rs730880056

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 7P and 4B. PM1PM5PP3_ModeratePP5BS2

The NM_000719.7(CACNA1C):​c.2579G>A​(p.Arg860Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R860P) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

9
6
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:4

Conservation

PhyloP100: 8.08

Publications

4 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 16 uncertain in NM_000719.7
PM5
Other missense variant is known to change same aminoacid residue: Variant chr12-2593261-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 180284.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.859
PP5
Variant 12-2593261-G-A is Pathogenic according to our data. Variant chr12-2593261-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 190654.
BS2
High AC in GnomAdExome4 at 25 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.2669G>A p.Arg890Gln missense_variant Exon 19 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.2744G>A p.Arg915Gln missense_variant Exon 20 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.2669G>A p.Arg890Gln missense_variant Exon 19 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.2669G>A p.Arg890Gln missense_variant Exon 19 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.2669G>A p.Arg890Gln missense_variant Exon 19 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.2669G>A p.Arg890Gln missense_variant Exon 19 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.2654G>A p.Arg885Gln missense_variant Exon 20 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.2654G>A p.Arg885Gln missense_variant Exon 20 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.2570G>A p.Arg857Gln missense_variant Exon 19 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.2579G>A p.Arg860Gln missense_variant Exon 19 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*1186G>A non_coding_transcript_exon_variant Exon 17 of 27 5 ENSP00000437936.2 F5H638
CACNA1CENST00000480911.6 linkn.*1186G>A 3_prime_UTR_variant Exon 17 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000121
AC:
3
AN:
248588
AF XY:
0.0000223
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000266
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000171
AC:
25
AN:
1461408
Hom.:
0
Cov.:
31
AF XY:
0.0000179
AC XY:
13
AN XY:
726928
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86114
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53384
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111774
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152200
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41444
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000241
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000165
AC:
2
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:2Uncertain:1
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 23, 2021
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 28616568, 29071820, 28600387) -

Timothy syndrome Pathogenic:1
Mar 25, 2019
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Wolff-Parkinson-White pattern Uncertain:1
Jul 14, 2017
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

This variant was identified in an individual with Wolff-Parkinson-White syndrome -

Long QT syndrome Uncertain:1
Sep 15, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This sequence change replaces arginine with glutamine at codon 860 of the CACNA1C protein (p.Arg860Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs730880056, ExAC 0.003%). This missense change has been observed in individuals with clinical features of long QT syndrome (PMID: 28600387, 28616568, 29071820, 31408100; Invitae). ClinVar contains an entry for this variant (Variation ID: 190654). This variant disrupts the p.Arg860 amino acid residue in CACNA1C. Other variant(s) that disrupt this residue have been observed in individuals with CACNA1C-related conditions (PMID: 25633834; Invitae), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
Mar 29, 2020
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R860Q variant (also known as c.2579G>A), located in coding exon 19 of the CACNA1C gene, results from a G to A substitution at nucleotide position 2579. The arginine at codon 860 is replaced by glutamine, an amino acid with highly similar properties. This variant has been reported in long QT syndrome (LQTS) cases; however, in some cases clinical details were limited and/or an additional cardiac variant was also detected (Mellor G et al. Circ Cardiovasc Genet, 2017 Jun;10:[Epub ahead of print]; Boles U et al. Int J Cardiol Heart Vasc, 2017 Jun;15:21-23; Seo SH et al. Ann Lab Med, 2018 Jan;38:54-58). Alternate amino acid substitutions at this codon, p.R860G and p.R860P, have also been associated with LQTS (Mellor GJ et al. Europace, 2019 Nov;21:1725-1732). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.48
CardioboostArm
Pathogenic
0.92
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Pathogenic
0.23
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.062
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Pathogenic
0.56
D
MetaRNN
Pathogenic
0.86
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.2
.;M;.;M;M;M;M;M;M;M;M;M;M;M;M;M;.;M;M;M;.;.;.
PhyloP100
8.1
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-2.9
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
0.65
Sift
Benign
0.057
T;T;D;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;D;T;D
Sift4G
Benign
0.13
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
1.0, 1.0, 0.77, 0.41, 0.88, 1.0, 1.0
.;D;D;P;B;P;D;D;D;P;D;D;D;D;D;D;.;D;D;.;D;.;D
Vest4
0.79
MVP
0.94
MPC
2.0
ClinPred
0.86
D
GERP RS
4.9
gMVP
0.80
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs730880056; hg19: chr12-2702427; API